blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2288613

EP2288613 - PHENYL-SUBSTITUTED 2-IMINO-3-METHYL PYRROLO PYRIMIDINONE COMPOUNDS AS BACE-1 INHIBITORS, COMPOSITIONS, AND THEIR USE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.05.2017
Database last updated on 22.08.2024
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR		published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
[2016/28]
Former [2012/33]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway NJ 07065-0907 / US
Former [2011/09]For all designated states
Schering Corporation
2000 Galloping Hill Road
Kenilworth, NJ 07033 / US
Inventor(s)01 / STAMFORD, Andrew, W.
27 Overlook Road
Chatham Township NJ 07928 / US
02 / ZHU, Zhaoning
6 Cypress Court
Plainsboro NJ 08536 / US
03 / MANDAL, Mihirbaran
181 Spruce Mill Lane 181
Scotch Plains NJ 07076 / US
04 / WU, Yusheng
235 East 40th Street Apt. 20c
New York NY 10016 / US
05 / CUMMING, Jared, N.
417 Center Street
Garwood NJ 07027 / US
06 / LIU, Xiaoxiang
551 Cleveland Avenue
River Vale NJ 07675 / US
07 / LI, Guoqing
19 Waters Lane
Belle Mead NJ 08502 / US
08 / ISERLOH, Ulrich
1110 Park Avenue Apt. 2l
Hoboken NJ 07030 / US
 [2011/09]
Representative(s)Jaap, David Robert, et al
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
[N/P]
Former [2016/28]Buchan, Gavin MacNicol
Merck & Co., Inc.
European Patent Department
Hertford Road
Hoddesdon, Hertfordshire EN11 9BU / GB
Former [2011/09]Buchan, Gavin MacNicol
Merck & Co., Inc. European Patent Department Hertford Road
Hoddesdon, Hertfordshire EN11 9BU / GB
Application number, filing date09734237.221.04.2009
[2011/09]
WO2009US41202
Priority number, dateUS20080047006P22.04.2008         Original published format: US 47006 P
[2016/26]
Former [2011/09]US2008004700622.04.2008
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009131975
Date:29.10.2009
Language:EN
[2009/44]
Type: A1 Application with search report 
No.:EP2288613
Date:02.03.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 29.10.2009 takes the place of the publication of the European patent application.
[2011/09]
Type: B1 Patent specification 
No.:EP2288613
Date:13.07.2016
Language:EN
[2016/28]
Search report(s)International search report - published on:EP29.10.2009
ClassificationIPC:C07D487/04, A61P25/28, A61K31/519
[2011/09]
CPC:
C07D487/04 (EP,US); A61P11/02 (EP); A61P13/12 (EP);
A61P25/00 (EP); A61P25/16 (EP); A61P25/28 (EP);
A61P27/00 (EP); A61P27/06 (EP); A61P3/10 (EP);
A61P31/00 (EP); A61P43/00 (EP); A61P7/08 (EP);
A61P9/00 (EP); A61P9/10 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/28]
Former [2011/09]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL22.11.2010
BA22.11.2010
RS22.11.2010
TitleGerman:PHENYLSUBSTITUIERTE 2-IMINO-3-METHYLPYRROLOPYRIMIDINONVERBINDUNGEN ALS BACE-1-INHIBITOREN, ZUSAMMENSETZUNGEN UND DEREN VERWENDUNG[2011/09]
English:PHENYL-SUBSTITUTED 2-IMINO-3-METHYL PYRROLO PYRIMIDINONE COMPOUNDS AS BACE-1 INHIBITORS, COMPOSITIONS, AND THEIR USE[2011/09]
French:COMPOSES DE 2-IMINO-3-METHYL-PYRROLO PYRIMIDINONE SUBSTITUES PAR PHENYLE UTILISES EN TANT QU INHIBITEURS BACE-1, COMPOSITIONS ET UTILISATION ASSOCIEES[2011/09]
Entry into regional phase22.11.2010National basic fee paid 
22.11.2010Designation fee(s) paid 
22.11.2010Examination fee paid 
Examination procedure08.11.2010Amendment by applicant (claims and/or description)
22.11.2010Examination requested  [2011/09]
16.06.2014Despatch of a communication from the examining division (Time limit: M04)
15.10.2014Reply to a communication from the examining division
11.03.2015Despatch of a communication from the examining division (Time limit: M06)
16.09.2015Reply to a communication from the examining division
03.02.2016Communication of intention to grant the patent
26.05.2016Receipt of the translation of the claim(s)
27.05.2016Fee for grant paid
27.05.2016Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.06.2014
Opposition(s)18.04.2017No opposition filed within time limit [2017/25]
Fees paidRenewal fee
06.04.2011Renewal fee patent year 03
21.03.2012Renewal fee patent year 04
26.03.2013Renewal fee patent year 05
26.03.2014Renewal fee patent year 06
08.04.2015Renewal fee patent year 07
30.03.2016Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.04.2009
AT13.07.2016
BE13.07.2016
CY13.07.2016
CZ13.07.2016
DK13.07.2016
EE13.07.2016
ES13.07.2016
FI13.07.2016
HR13.07.2016
IT13.07.2016
LT13.07.2016
LV13.07.2016
MC13.07.2016
MK13.07.2016
NL13.07.2016
PL13.07.2016
RO13.07.2016
SE13.07.2016
SI13.07.2016
SK13.07.2016
TR13.07.2016
BG13.10.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
[2020/15]
Former [2019/51]HU21.04.2009
AT13.07.2016
BE13.07.2016
CY13.07.2016
CZ13.07.2016
DK13.07.2016
EE13.07.2016
ES13.07.2016
FI13.07.2016
HR13.07.2016
IT13.07.2016
LT13.07.2016
LV13.07.2016
MC13.07.2016
MK13.07.2016
NL13.07.2016
PL13.07.2016
RO13.07.2016
SE13.07.2016
SI13.07.2016
SK13.07.2016
BG13.10.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
Former [2019/46]HU21.04.2009
AT13.07.2016
BE13.07.2016
CY13.07.2016
CZ13.07.2016
DK13.07.2016
EE13.07.2016
ES13.07.2016
FI13.07.2016
HR13.07.2016
IT13.07.2016
LT13.07.2016
LV13.07.2016
MC13.07.2016
NL13.07.2016
PL13.07.2016
RO13.07.2016
SE13.07.2016
SI13.07.2016
SK13.07.2016
BG13.10.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
Former [2019/31]HU21.04.2009
AT13.07.2016
BE13.07.2016
CZ13.07.2016
DK13.07.2016
EE13.07.2016
ES13.07.2016
FI13.07.2016
HR13.07.2016
IT13.07.2016
LT13.07.2016
LV13.07.2016
MC13.07.2016
NL13.07.2016
PL13.07.2016
RO13.07.2016
SE13.07.2016
SI13.07.2016
SK13.07.2016
BG13.10.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
Former [2018/06]AT13.07.2016
BE13.07.2016
CZ13.07.2016
DK13.07.2016
EE13.07.2016
ES13.07.2016
FI13.07.2016
HR13.07.2016
IT13.07.2016
LT13.07.2016
LV13.07.2016
MC13.07.2016
NL13.07.2016
PL13.07.2016
RO13.07.2016
SE13.07.2016
SI13.07.2016
SK13.07.2016
BG13.10.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
Former [2017/37]AT13.07.2016
BE13.07.2016
CZ13.07.2016
DK13.07.2016
EE13.07.2016
ES13.07.2016
FI13.07.2016
HR13.07.2016
IT13.07.2016
LT13.07.2016
LV13.07.2016
NL13.07.2016
PL13.07.2016
RO13.07.2016
SE13.07.2016
SI13.07.2016
SK13.07.2016
BG13.10.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
Former [2017/31]AT13.07.2016
BE13.07.2016
CZ13.07.2016
DK13.07.2016
EE13.07.2016
ES13.07.2016
FI13.07.2016
HR13.07.2016
IT13.07.2016
LT13.07.2016
LV13.07.2016
NL13.07.2016
PL13.07.2016
RO13.07.2016
SE13.07.2016
SK13.07.2016
BG13.10.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
Former [2017/13]AT13.07.2016
BE13.07.2016
ES13.07.2016
FI13.07.2016
HR13.07.2016
IT13.07.2016
LT13.07.2016
LV13.07.2016
NL13.07.2016
PL13.07.2016
SE13.07.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
Former [2017/11]AT13.07.2016
BE13.07.2016
ES13.07.2016
FI13.07.2016
HR13.07.2016
IT13.07.2016
LT13.07.2016
NL13.07.2016
PL13.07.2016
SE13.07.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
Former [2017/10]BE13.07.2016
FI13.07.2016
HR13.07.2016
IT13.07.2016
LT13.07.2016
NL13.07.2016
PL13.07.2016
SE13.07.2016
NO13.10.2016
IS13.11.2016
Former [2017/09]FI13.07.2016
IT13.07.2016
LT13.07.2016
NL13.07.2016
NO13.10.2016
Former [2017/07]LT13.07.2016
Cited inInternational search[ID]WO2006138264  (SCHERING CORP [US], et al) [ID] 1,18,20,29,34 * page 16, line 14 * * page 34, line 20 - line 23 ** claims 1,17,29,32,35,36 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.